Whole Blood vs. Plasma/Serum Viscosity: Why the Complete Profile Matters
Whole Blood vs. Plasma/Serum Viscosity: Why the Complete Profile Matters
Systolic & diastolic WBV • Non-Newtonian flow • Clinical decision support
Not all viscosity tests are created equal. Many labs measure plasma or serum viscosity only. Meridian Valley Lab measures whole blood viscosity (WBV)—and uniquely reports both systolic and diastolic values—to give clinicians a fuller picture of cardiovascular stress and blood-flow resistance.
Bottom line: Only whole blood captures red blood cell aggregation and non-Newtonian behavior—core drivers of real-world flow resistance.
Plasma, Serum, and Whole Blood—What’s the Difference?
Show Section
- Plasma: ~55% of blood; contains proteins, nutrients, and clotting factors; collected with anti-coagulant then centrifuged.
- Serum: plasma after clotting; lacks clotting factors. Both plasma/serum exclude RBCs, limiting insight into in-vivo flow.
- Whole blood: plasma plus red/white cells and platelets—reflects the true resistance the heart must overcome each beat.
Because plasma/serum remove cells, they cannot assess RBC aggregation or deformability—major determinants of viscosity at low shear.
Why Whole Blood Viscosity Is More Physically Meaningful
Show Section
Blood is a non-Newtonian fluid: viscosity changes with flow rate (shear).
- Systole (high shear): Blood thins as RBC aggregates disperse.
- Diastole (low shear): Blood thickens as RBCs re-aggregate; plasma proteins (e.g., fibrinogen) amplify this effect.
These dynamics cannot be seen in plasma/serum tests because cells are absent. WBV uniquely captures both ends of the cardiac cycle, aligning with oxygen delivery, endothelial stress, and thrombotic tendency.
What Makes Meridian Valley Lab’s Test Different
Show Details
- Complete WBV profile: We report systolic (high-shear) and diastolic (low-shear) viscosity. Most WBV offerings report systolic only.
- Instrument: Automated scanning capillary viscometer for direct whole-blood behavior.
- Regulatory: FDA-registered Class I device (21 CFR § 862.2920).
Result: A clinically actionable profile that parallels real hemodynamics rather than a partial surrogate.
How the Complete Profile Improves Patient Care
Show Section
- Risk assessment: Detect silent flow resistance contributing to cardiovascular and microcirculatory strain.
- Monitoring: Track response to hydration/electrolytes, omega-3s, activity, triglyceride control, and anti-inflammatory strategies.
- Personalization: Tailor interventions when diastolic (low-shear) viscosity is the dominant issue vs. high-shear changes.
Important Interpretation Notes
Measured parameter, not diagnosis: MVL reports whole blood viscosity to inform clinical decision-making. Results must be interpreted by licensed clinicians alongside history, exam, and other labs. Billing: Not covered by insurance; providers bill patients directly.
Experience the Difference with Meridian Valley Lab
Show CTA
Meridian Valley Lab is proud to offer a complete systolic and diastolic WBV profile for deeper cardiovascular insight.
Practitioners: Contact Client Services to order or discuss interpretation.
Patients: Ask your licensed provider whether WBV testing fits your prevention or treatment plan. Meridian Valley Lab provides laboratory services only and cannot advise patients directly.
Call: 855.405.8378 | 206.209.4200
